Skip to main content

Table 1 Characteristics and treatments of the subjects at baseline

From: Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

Variable Value
Number 12
Sex (male/female) 5/7
Age (years) 59.5 ± 9.4
Antidiabetic treatments  
Diet alone 2
Oral hypoglycemic agents 10
Sulfonylurea 2
Glinide 3
Metformin 3
α-glucosidase inhibitor 5
Dipeptidyl peptidase-4 inhibitor 5
Thiazolidinedione 0
Insulin 0
Hypolipidemic agents  
Fenofibrate 0
Statin 1
Ezetimibe 4
None 7
  1. Data are shown as the mean ± standard deviation or n.